EZR and hepatocellular carcinoma: In addition, the binding of celastrol to ROCK2 inhibits the migration of hepatocellular carcinoma, mainly through the impaired ROCK2-mediated phosphorylation of ezrin, resulting in ineffective ezrin activation [285].